A CO ₂ -responsive well-defined magneto-polymeric drug delivery system has been developed. A dosage release of doxorubicin (DOX) in vitro in a time-controllable manner can be easily executed with alternate CO ₂ /N ₂ treatment by these smart nanocarriers.
No takes yet. Share an insight, caveat, or question.
Che et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: